ERBB2 and breast cancer: The pCR rate and survival did not differ markedly across the three HER2 subtypes.<h4>Conclusions</h4>HER2-low breast cancer is distinct from HER2-0 and HER2-high breast cancer with respect to clinicopathological characteristics.